ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. 

Biotechnology

ALX Oncology

ALX Oncology's headquarters in Burlingame, CA, United States

Hadi Falahatpisheh

Marija Vrljic

Athanasios Tsiatis

Jeanne Jew

Hank Stern

Susan Vermeir

Yeong-Liang Lin

Linda Woo

Lisa Sauer

Connie Lu

Charlie Zhang

Shanhong Guan

Sarah Bolton

Lori Lautenbach

Mary Liu

Lori Richter

Danny Ooi

Jacqueline Giang

Avery T.

Julie Bacon

Emmanuel Ang

Keith Flaherty

Charles M. Baum

Corey Goodman

Rekha Hemrajani

Jack B. Nielsen

Jason Lettmann

Scott Garland

The Clinical Development and Operations team at ALX Oncology is responsible for designing, implementing, and managing clinical trials that evaluate the safety and efficacy of innovative cancer therapies targeting the CD47 checkpoint pathway. This team collaborates across various functions to ensure that clinical studies are conducted efficiently, adhere to regulatory standards, and generate reliable data to support the company's mission of advancing immuno-oncology treatments for patients.

Clinical Development and Operations

The Leadership Team at ALX Oncology drives strategic initiatives and oversees the development of innovative therapies to combat cancer. Comprising executives from clinical development, scientific research, finance, and regulatory affairs, this team ensures alignment across all departments, guides project prioritization, and fosters collaboration to advance the company's clinical programs and optimize resource allocation for successful outcomes.

Leadership Team

The Regulatory Affairs and Compliance team at ALX Oncology is responsible for ensuring that the company's clinical therapies meet all regulatory standards and guidelines throughout the development process. This team collaborates closely with biostatisticians and quality assurance professionals to secure and maintain approvals from regulatory agencies, ensuring that ALX's innovative immuno-oncology treatments are safe, effective, and compliant with industry regulations.

Regulatory Affairs and Compliance

��

ALX Oncology

Org chart

Board & advisors

Teams

Clinical Development and Operations

Leadership Team

Regulatory Affairs and Compliance

Offices

��������

ALX Oncology

Org chart

Board & advisors

Teams

Clinical Development and Operations

Leadership Team

Regulatory Affairs and Compliance

Offices

Related companies

��